Search for: ""Daubert v. Merrell Dow Pharmaceuticals, Inc." OR "509 U.S. 579"" Results 61 - 80 of 112
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Feb 2013, 4:37 am by Susan Brenner
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
24 Jan 2013, 8:09 am by Alex Craigie
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579), federal courts have applied a different standard. [read post]
27 Dec 2012, 5:07 am by Erin Kristofco
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593-94 (1993) are relevant to the Court’s reliability determination under CRE 702, which is identical to FRE 702. [read post]
24 Dec 2012, 9:58 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), a case that has been superseded by subsequent cases and a revision to the operative statute, Rule 702. [read post]
19 Jul 2012, 4:07 pm by Schachtman
Evid. 702 2000 advisory commitee’s note; Daubert, 509 U.S. at 593, 113 S.Ct. 2786. [read post]
18 Apr 2012, 1:14 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) provided a number of factors that typically 'bear on the inquiry'. [read post]
25 Jan 2012, 6:42 am by emagraken
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786 (1993), and discussed in Taylor v. [read post]
9 Nov 2011, 6:30 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and progeny. [read post]
25 Oct 2011, 9:05 am by Robert C. Weill
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 595 (1993), that “[e]xpert evidence can be both powerful and quite misleading because of the difficulty in evaluating it. [read post]
21 Jun 2011, 5:00 am by Bexis
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), applies to class certifications. [read post]
13 May 2011, 1:44 pm by WIMS
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]